IDO Peptid Vaccination for Stage III-IV Non Small-cell Lung Cancer Patients.
Clinical trial NCT01219348 · COMPLETED
Trial details
- NCT number
- NCT01219348
- Sponsor
- Inge Marie Svane
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2010-06-01
- Primary completion
- 2012-08-01
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.